The relationship between BPAQ-derived physical activity and bone density of middle-aged and older men

- Bolam, K. A., Beck, B. R., Adlard, K. N., Skinner, T. L., Cormie, P., Galvao, D. A., Spry, N., Newton, R. U., Taaffe, D. R.

Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: a randomized controlled trial

- Cormie, P., Newton, R. U., Taaffe, D. R., Spry, N., Joseph, D., Hamid, M. Akhlil, Galvao, D. A.

Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases

- Cormie, P., Newton, R. U., Spry, N., Joseph, D., Taaffe, D. R., Galvão, D. A.

AST-induced bone loss in men with prostate cancer: exercise as a potential countermeasure

- Bolam, K. A., Galväo, D. A., Spry, N., Newton, R. U., Taaffe, D. R.

The GOFURTGO study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer

- Goldstein, D., Spry, N., Shapiro, J., Porter, I. W. T., Hruby, G., Horvath, L., Bydder, S., Underhill, C., Harvey, J., Gebski, V. J., Cummins, M. M., Brown, C., van Hazel, G. A., Carroll, S., Selva-Nayagam, S., Borg, M., Ackland, S. P., Wratten, C.